Semaglutide is a long-acting GLP-1 receptor agonist engineered for enhanced stability and prolonged activity in metabolic research models. It is studied for its interaction with incretin signaling pathways, influencing insulin secretion, glucagon regulation, and gastric emptying mechanisms. Research has focused on its role in glucose metabolism, appetite signaling, and energy balance through endocrine system modulation. Its structural modifications enable extended half-life and sustained receptor activation in controlled laboratory conditions. Additional investigations evaluate receptor binding affinity and downstream signaling cascades associated with metabolic regulation. Ongoing research continues to examine its pharmacokinetic profile and biochemical behavior across experimental systems.